A phase II clinical trial of ZD1839 ( gefitinib) in combination with docetaxel as first-line treatment in patients with advanced breast cancer

被引：0
|
作者：
Dennison, S. K.
Jacobs, S. A.
Wilson, J.
Seeger, J.
Cescon, T.
Raymond, J. M.
Geyer, C. E.
Wolmark, N.
Swain, S. M.
机构：
[1] Walter Reed Army Med Ctr, Washington, DC 20307 USA
[2] NSABP, Pittsburgh, PA USA
[3] Norton Hlth Care, Louisville, KY USA
[4] Berks Hematol & Oncol Associates, Reading, PA USA
[5] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[6] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1059
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II Trial of XELOX as First-Line Treatment for Patients with Advanced Gastric Cancer
    Luo, Hui-yan
    Xu, Rui-hua
    Wang, Feng
    Qiu, Miao-zhen
    Li, Yu-hong
    Li, Fang-hua
    Zhou, Zhi-wei
    Chen, Xiao-qin
    CHEMOTHERAPY, 2010, 56 (02) : 94 - 100
  • [22] Gefitinib (ZD1839) combined with weekly epirubicin in patients with metastatic breast cancer: a phase I study with biological correlate
    Gasparini, G
    Sarmiento, R
    Amici, S
    Longo, R
    Gattuso, D
    Zancan, M
    Gion, M
    ANNALS OF ONCOLOGY, 2005, 16 (12) : 1867 - 1873
  • [23] Prognostic value of serum sEGFR and EGFR mutations in a phase II trial of gefitinib (Iressa®, ZD1839) in women with endometrial cancer
    Leslie, Kimberly
    Sill, Michael
    Darcy, Kathleen
    Baron, Andre
    Wilken, Jason
    Godwin, Andrew
    Cook, Linda
    Schilder, Russell
    Schilder, Jeanne
    Maihle, Nita
    CANCER RESEARCH, 2009, 69
  • [24] Apatinib in combination with S-1 as first-line treatment in patients with advanced gastric cancer: A phase II clinical trial.
    Zhang, Chuantao
    Liu, Zimin
    Zhou, Na
    Zhang, Jianli
    Zhu, Jingjuan
    Lv, Hongying
    Li, Tianjun
    Hou, Helei
    Liu, Dong
    Cong, Jing
    Jiang, Man
    Liu, Kewei
    Cui, Zhumei
    Zhou, Yanbing
    Zhang, Xiaochun
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [25] Phase II Study of Bevacizumab in Combination with Docetaxel and Capecitabine for the First-Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer
    Musolino, A.
    Bisagni, G.
    De Matteis, A.
    Nuzzo, F.
    Ardizzoni, A.
    Crino, L.
    Gamucci, T.
    Passalacqua, R.
    Gnoni, R.
    Boni, C.
    CANCER RESEARCH, 2010, 70
  • [26] Docetaxel and gefitinib in the first-line treatment of elderly patients (≥ 70) with advanced non-small cell lung cancer (ANSCLC):: Results of phase II trial.
    Beple, G
    Williams, CC
    Chiappori, A
    Antonia, SJ
    Haura, EB
    Mahany, JJ
    Galloway, T
    Simon, GR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 659S - 659S
  • [27] Determinants of response to gefitinilb (Iressa®, ZD1839) in patients with advanced breast cancer.
    Iacobuzio-Donahue, CA
    Albain, K
    Elledge, R
    Gradishar, W
    Hayes, D
    Rowinsky, E
    Hudis, C
    Pusztai, L
    Tripathy, D
    Modi, S
    Rubin, S
    Hidalgo, M
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6092S - 6092S
  • [28] Docetaxel and epirubicin as first-line treatment for patients with metastatic breast cancer: A minnie pearl cancer research network phase II trial
    Hainsworth, John D.
    Yardley, Denise A.
    Spigel, David R.
    Meluch, Anthony A.
    Rinaldi, David
    Schnell, Frederick M.
    Greco, F. Anthony
    CANCER INVESTIGATION, 2006, 24 (05) : 469 - 473
  • [29] Infusional 5-fluorouracil and ZD1839 (gefitinib-iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: A Phase I and II trial (18391L/0092)
    Valentini, Vincenzo
    De Paoli, Antonino
    Gambacorta, Maria Antonietta
    Mantini, Giovanna
    Ratto, Carlo
    Vecchio, Fabio Maria
    Barbaro, Brunella
    Innocente, Roberto
    Rossi, Carlo
    Boz, Giovanni
    Barba, Maria Cristina
    Frattegiani, Alessandro
    Lupattelli, Marco
    Doglietto, Giovan Battista
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 644 - 649
  • [30] VINORELBINE AND DOCETAXEL COMBINATION AS FIRST LINE TREATMENT IN PATIENTS WITH METASTATIC BREAST CANCER - RESULTS OF A MULTICENTRIC PHASE II TRIAL IN IRAN
    Ameri, A.
    Shahrad, B.
    Madani, H.
    Fazlalizadeh, A.
    Mousavizadeh, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 119 - 119
12345